Chemist Warehouse says booming demand for blockbuster weight-loss drugs is driving double-digit sales growth at its pharmacies and demand will only accelerate if cheaper pill versions of the weekly injections hit the Australian market this year as expected.
Shares in Sigma Healthcare, which merged with Chemist Warehouse last year, rose 2.3 per cent to $3.06 on Thursday after the retail and pharmacy giant said sales growth accelerated in the second quarter, and remained robust into the third quarter of the fiscal year.
